Douglas R. Green, Ph.D., chair of the St. Jude Childen’s Research Hospital Department of Immunology and Peter C. Doherty Endowed Chair of Immunology at St. Jude, is one of four recipients of the 2019 Wilbur Lucius Cross Medal for Alumni Achievement from the Yale Graduate School of Arts and Sciences.
Green earned his Bachelor of Science degree from Yale in 1977, as well as his doctorate in immunology in 1981. He completed his postdoctoral work in experimental surgery and marine ecology at Yale as well.
Green’s research at St. Jude focuses on the process of active cell death and cell survival, extending from the role of cell death in the regulation of cancer and immune responses in the whole organism to the fundamental molecular events directing the death of the cell. He has published more than 600 papers, chapters, commentaries and books.
In 2017, Green was awarded the Jurg Tschopp Prize for research on cell death. He is an honorary fellow of Trinity College in Dublin, an honorary Einstein Professor in China, a foreign fellow of the Royal Society of Canada, and an honorary Ph.D. degree recipient from University Tor Vergata in Rome. His most recent book, “Apoptosis and Other Cell Death Mechanisms: Means to an End,” was published in 2018.
The Cross Medal recognizes the continued legacy of service and excellence inaugurated by Wilbur Lucius Cross (Ph.D. 1889), who served as dean of the Yale Graduate School from 1916 to 1930, and governor of Connecticut from 1930 to 1939.
Joining Green as honorees in 2019 are philosopher Ruth Garrett Millikan, ’69, Ph.D.; geologist and paleoecologist Susan M. Kidwell, ’82, Ph.D.; and economist Urjit Ravindra Patel, ’90, Ph.D. All four recipients will present talks about their work during their visit to campus on Oct. 7 to receive their awards.
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital is leading the way the world understands, treats and cures childhood cancer and other life-threatening diseases. It is the only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children. Treatments developed at St. Jude have helped push the overall childhood cancer survival rate from 20 percent to 80 percent since the hospital opened more than 50 years ago. St. Jude freely shares the breakthroughs it makes, and every child saved at St. Jude means doctors and scientists worldwide can use that knowledge to save thousands more children. Families never receive a bill from St. Jude for treatment, travel, housing and food — because all a family should worry about is helping their child live. To learn more, visit stjude.org or follow St. Jude on social media at @stjuderesearch.